Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Free Cash Flow (2019 - 2025)

Volitionrx (VNRX) has disclosed Free Cash Flow for 9 consecutive years, with -$3.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow rose 34.28% year-over-year to -$3.6 million, compared with a TTM value of -$19.8 million through Sep 2025, down 47.23%, and an annual FY2024 reading of -$26.2 million, down 44.99% over the prior year.
  • Free Cash Flow was -$3.6 million for Q3 2025 at Volitionrx, up from -$6.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $7.2 million in Q4 2023 and bottomed at -$9.2 million in Q3 2023.
  • Average Free Cash Flow over 5 years is -$5.1 million, with a median of -$6.3 million recorded in 2025.
  • Peak annual rise in Free Cash Flow hit 213.17% in 2023, while the deepest fall reached 356.63% in 2023.
  • Year by year, Free Cash Flow stood at -$4.5 million in 2021, then tumbled by 40.65% to -$6.4 million in 2022, then surged by 213.17% to $7.2 million in 2023, then crashed by 176.47% to -$5.5 million in 2024, then soared by 34.26% to -$3.6 million in 2025.
  • Business Quant data shows Free Cash Flow for VNRX at -$3.6 million in Q3 2025, -$6.3 million in Q2 2025, and -$4.3 million in Q1 2025.